Nila

Five ancestries do not guarantee five replications

For the reported MDD–VTE genetic relationship, ancestry breadth is a replication signal only if each analysis uses independent cohorts and produces ancestry-specific estimates with concordant direction. A pooled five-ancestry result could instead retain sample overlap, shared controls, correlated phenotypes, or reuse of discovery inputs. The claim remains provisional unless matched phenotype definitions and cohort independence are documented and heterogeneity is reported rather than absorbed into the combined estimate.

PTSD–OSA overlap needs independent trait replication

The claim is shared genetic architecture between PTSD and obstructive sleep apnea. Replication signal would require concordant effects in non-overlapping cohorts, with each phenotype defined consistently and results retained after ancestry-specific analysis. The title does not resolve shared controls, sample overlap, correlated behavioral or metabolic traits, or whether the same discovery data support every analytic method; these dependencies could make cross-method agreement look like replication.

For the stated Graves’ disease–prostate cancer claim, agreement among analytic methods is robustness, not replication, if they inherit the same GWAS inputs. A stronger test would repeat the causal estimate with non-overlapping outcome data and independently selected instruments, then assess the proposed shared mechanisms in a separate dataset; otherwise correlated source bias remains unresolved.

Graves’ disease–prostate cancer causality remains a replication question

The claim is a causal association with shared mechanisms between Graves’ disease and prostate cancer. Combining Mendelian randomization, machine learning, and bioinformatics may provide methodological triangulation, but it is not independent replication when analyses reuse the same cohorts, instruments, or underlying association data. Replication would require non-overlapping datasets, stable direction and magnitude across ancestry-specific analyses, validated instruments without material pleiotropy, and confirmation of any proposed mechanism in evidence not used to generate it.

Five ancestry strata are not automatically five replications

A genetic relationship between major depressive disorder and venous thromboembolism should count as replicated only when directionally concordant estimates arise from independent samples using matched phenotype definitions and prespecified variants or models. Ancestry-specific agreement could provide replication signal, but the title alone leaves cohort overlap, shared controls, phenotype harmonization, power imbalance, and model reuse unresolved; pooled cross-ancestry significance cannot substitute for independent within-ancestry confirmation.

Count only cohorts that could falsify the hypertension association

AGTR1 and CYP11B2 polymorphisms are claimed to influence hypertension susceptibility, but a pooled candidate-gene signal is not itself replication. Cohorts should count as replication only if they are independent of discovery samples, test the same allele and phenotype definition, and report ancestry-specific effects without post hoc model selection; overlap, small-study effects, selective reporting, and ancestry-dependent heterogeneity remain unresolved from the metadata. The key result is whether adequately powered independent cohorts show directionally consistent effects after discovery-linked datasets are removed.